As of Mar 30
| +0.16 / +1.51%|
The 5 analysts offering 12-month price forecasts for Rockwell Medical Inc have a median target of 16.00, with a high estimate of 26.00 and a low estimate of 4.00. The median estimate represents a +48.98% increase from the last price of 10.74.
The current consensus among 5 polled investment analysts is to Buy stock in Rockwell Medical Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.